Boots began reprinting batch identifiers on No7 Protect & Perfect Advanced Serum cartons Monday after social threads and in-store returns highlighted viscosity changes in bottles approaching printed expiry, according to a pharmacist circular from Walgreens Boots Alliance reviewed by InfoHandle. The reform is labelling and traceability, not a formula swap—MHRA treats the product as a cosmetic, so there is no medicines recall class—but stores must quarantine lots listed on an internal portal until accelerated stability checks clear them for shelf.
What is in the bottle and who sold the claim
INCI lists show peptides, hyaluronic acid, and dimethicone among actives; No7 marketing claims "visible wrinkle reduction" tested on panels Boots sponsors. ASA rulings on No7 lines historically require substantiation files on request, not on-pack trial data. Customers confused separation with spoilage; chemists note emulsion drift can occur near temperature swings in shop windows, which is why batch codes now include month-year manufacturing stamps readable without peeling box flaps.
What stores must do
Pharmacists scan outgoing stock against the portal list; unaffected batches stay on sale. Returns with matching codes get full refunds even without receipt if lot numbers align—Boots tightened that policy after threads accused staff of blaming bathroom storage. Online orders ship from warehouses with separate lot control; marketplace third parties are excluded.
What shoppers can check
Match the embossed lot on the bottle crimp to the carton code; photograph both if lodging a query. MHRA cosmetic reporting accepts consumer notifications but does not approve formulations. If serum smells off or stings beyond normal acid tingle, stop use and return—stability testing is about shelf life, not individual allergy. Boots expects revised labels nationwide by October; until then, check the portal list if your bottle looks cloudy near expiry.
Competitors and shelf context
Superdrug and department-store peptide serums sit adjacent on many high streets; Boots is not alone in facing temperature-related returns, but No7 is its house margin driver, so traceability matters for investor calls as much as forums. Pharmacists without beauty counters still receive the circular because click-and-collect lockers heat up in summer sun—store ops moved some serum facings away from window lines this month.
Evidence limits
No peer-reviewed paper backs every No7 claim on pack; Boots cites internal panel studies. ASA has not opened a new case on this batch issue; consumer threads are not adjudication. If quarantined lots fail accelerated tests, Boots must destroy stock and notify trading standards—customers who kept bottles from listed codes should return them even if liquid looks fine.
Beauty hall managers said the relabel run should not empty shelves nationwide—only flagged lots pause—so routine shoppers need not panic-buy alternatives unless their bottle matches the portal.